Elevated serum CA19-9, CEA, CD44 variant 6 (CD44v6), and integrin-β1 levels were found to be closely related to the progression and metastasis of pancreatic cancers [7]. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.